Genmab A/S (GMAB)

Genmab Stock Forecast

Stock Price Forecast

The 5 analysts that cover Genmab stock have a consensus rating of "Strong Buy" and an average price target of $40.4, which forecasts a 33.25% increase in the stock price over the next year. The lowest target is $27 and the highest is $48.

Price Target: $40.4 (+33.25%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$27	$40.4	$43	$48
Change	-10.95%	+33.25%	+41.82%	+58.31%

Analyst Ratings

The average analyst rating for Genmab stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	3	2	2	4	4	4
Buy	4	4	3	3	3	2
Hold	2	2	2	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	8	7	7	7	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $40 → $41	Strong Buy	Maintains	$40 → $41	+35.22%	Nov 10, 2025
Asthika Goonewardene Truist Securities	Truist Securities	Strong Buy Reiterates $49 → $48	Strong Buy	Reiterates	$49 → $48	+58.31%	Nov 7, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $40	Strong Buy	Reiterates	$40	+31.93%	Oct 15, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $36 → $40	Strong Buy	Maintains	$36 → $40	+31.93%	Oct 2, 2025
Michael Schmitz Guggenheim	Guggenheim	Hold → Strong Buy Upgrades $43	Hold → Strong Buy	Upgrades	$43	+41.82%	Sep 24, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.73B

Increased by 24.92%

from 2.99B

Revenue Next Year

4.33B

Increased by 15.97%

from 3.73B

EPS This Year

17.34

Increased by 2.90%

from 16.85

EPS Next Year

19.58

Increased by 12.95%

from 17.34

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.66B	1.29B	2.08B	2.44B	2.99B	3.73B	4.33B
Revenue Growth	106.20%	-22.52%	61.88%	17.23%	22.32%	24.92%	15.97%
EPS	11.87	6.85	11.87	9.79	16.85	17.34	19.58
EPS Growth	132.20%	-42.30%	73.29%	-17.49%	72.08%	2.90%	12.95%
Forward PE	-	-	-	-	-	1.75	1.55
No. Analysts	-	-	-	-	-	23	24

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	4.0B	4.8B
Avg	3.7B	4.3B
Low	3.5B	3.9B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	33.7%	29.5%
Avg	24.9%	16.0%
Low	16.3%	3.6%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	19.98	26.53
Avg	17.34	19.58
Low	13.89	10.66

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	18.6%	53.1%
Avg	2.9%	12.9%
Low	-17.6%	-38.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.